Anti-BCL2L12 Antibody (R2R09)

Catalog No.

RHN74201

Species reactivity

Human

Host species

Rabbit

Isotype

IgG

Clonality

Monoclonal

Tested applications

FCM: 1:20-1:100, IF: 1:50-1:200, IHC: 1:100-1:200, IP: 1:20-1:50, WB: 1:1000-1:2000

Target

Bcl-2-related proline-rich protein, Bcl2-L-12, BCL2L12, BPR, Bcl-2-like protein 12

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

Q9HB09

Applications

FCM, IF, IHC, IP, WB

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 0.05% BSA, 50% Glycerol, 0.05% Sodium azide.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 4 ℃ for frequent use. Store at -20 ℃ for twelve months from the date of receipt.

Clone ID

R2R09

Alternative splicing in ovarian cancer., PMID:39425166

Soluble CD83 alleviates experimental allergic rhinitis through modulating antigen-specific Th2 cell property., PMID:31929750

BCL2L12 protein overexpression is associated with favorable outcome in diffuse large B-cell lymphoma patients in the rituximab era., PMID:27442703

The novel function of CD82 and its impact on BCL2L12 via AKT/STAT5 signal pathway in acute myelogenous leukemia cells., PMID:26260387

Spherical nucleic acid nanoparticle conjugates as an RNAi-based therapy for glioblastoma., PMID:24174328

Expression of Bcl2L12 in chronic lymphocytic leukemia patients: association with clinical and molecular prognostic markers., PMID:23292833

Bcl2L12 inhibits post-mitochondrial apoptosis signaling in glioblastoma., PMID:17210792

Document Download

Anti-BCL2L12 Antibody (R2R09).pdf